By Dr Alexandra Hogan

Preprints

Gupta M; Zoega H; Stopard I; Liu B; Macartney K; Wood J; Hogan A, 2026, Age-specific burden of medically attended respiratory virus disease in high-income countries: a scoping review and meta-analysis, http://dx.doi.org/10.64898/2026.06.09.26354660

Hogan A; Muscatello D; Liu B; Nedjati-Gilani G; Wood J, 2025, Capturing SARS-CoV-2 immune landscapes to inform future strategies for COVID-19 vaccination in a high-income setting: a mathematical modelling study, http://dx.doi.org/10.1101/2025.03.18.25324222

Ramsay E; Stocks N; Bernando C; Nobre F; Stepien S; Gonzalez-Chica D; Prasad S; Dore G; Macartney K; Wood J; Walsh D; Newall A; Cheng A; Hogan A; Bindra G; Wilkins D; Liu B, 2025, Characteristics of post-acute COVID-19 presentations and healthcare use in Australian general practice and comparisons to those with acute COVID-19 and upper respiratory tract infection, http://dx.doi.org/10.21203/rs.3.rs-7561005/v1

Bicego A; Wood J; Newall A; Hogan A, 2025, Effectiveness of maternal vaccines and long-acting monoclonal antibodies against respiratory syncytial virus hospitalisations in early life: a scoping review of dynamic modelling studies, http://dx.doi.org/10.1101/2025.04.16.25325979

Barnsley G; Mesa DO; Hogan A; Winskill P; Torkleson A; Walker D; Ghani A; Watson O, 2023, Impact of 100 Days Vaccination Mission on COVID-19: A Mathematical Modelling Study, http://dx.doi.org/10.2139/ssrn.4519550

Hogan AB; Wu SL; Toor J; Doohan P; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC, 2022, Long Term Vaccination Strategies to Mitigate the Global Impact of SARS-CoV-2 Transmission: A Modelling Study, http://dx.doi.org/10.2139/ssrn.4135323

Haw D; Forchini G; Christen P; Bajaj S; Hogan A; Winskill P; Miraldo M; White P; Ghani A; Ferguson N; Smith P; Hauck K, 2021, The costs of keeping schools open during the COVID-19 pandemic, http://dx.doi.org/10.21203/rs.3.rs-283318/v1

Unwin HJT; Mwandigha L; Winskill P; Ghani AC; Hogan AB, Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage, http://dx.doi.org/10.1101/2020.10.09.20209973

Hogan AB; Doohan P; Wu SL; Mesa DO; Toor J; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC, Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach, http://dx.doi.org/10.1101/2023.01.03.23284131

Imai N; Hogan AB; Williams L; Cori A; Mangal TD; Winskill P; Whittles LK; Watson OJ; Knock ES; Baguelin M; Perez-Guzman PN; Gaythorpe KAM; Sonabend R; Ghani AC; Ferguson NM, Interpreting estimates of coronavirus disease 2019 (COVID-19) vaccine efficacy and effectiveness to inform simulation studies of vaccine impact: a systematic review, http://dx.doi.org/10.12688/wellcomeopenres.16992.1

Hogan AB; Wu SL; Toor J; Mesa DO; Doohan P; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC, Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling study, http://dx.doi.org/10.1101/2023.02.09.23285743

Giannini F; Hogan AB; Sarna M; Glass K; Moore HC, Modelling the Age-Specific Risk of Hospitalisation Due to Rsv Infection, http://dx.doi.org/10.2139/ssrn.4654754

Le TP; Abell I; Conway E; Campbell PT; Hogan AB; Lydeamore MJ; McVernon J; Mueller I; Walker CR; Baker CM, Modelling the impact of hybrid immunity on future COVID-19 epidemic waves, http://dx.doi.org/10.1101/2023.03.12.23287174

Giannini F; Hogan AB; Blyth CC; Glass K; Moore HC, Modelling the impact of long-acting monoclonal antibody, maternal vaccine and hybrid programs of RSV immunisation in temperate Western Australia, http://dx.doi.org/10.64898/2026.03.02.26347477

Hogan AB; Mitchell A; Stadler E; Chung Y; Reynaldi A; Elias KM; Docken S; Khoury DS; Schlub T; Davenport MP; Cromer D, Quantifying the association between neutralising antibodies and protection from RSV disease in infants and adults: A systematic review and meta-analysis, http://dx.doi.org/10.64898/2026.02.13.26346212

Whittaker C; Barnsley G; Mesa DO; Laydon DJ; Tan CW; Zhu F; Johnson R; Doohan P; Nedjati-Gilani G; Winskill P; Hogan AB; Deol A; Mukandavire C; Hauck K; Lye DCB; Wang L-F; Watson OJ; Ghani AC, Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic, http://dx.doi.org/10.1101/2024.08.12.24311730

Imai N; Rawson T; Knock ES; Sonabend R; Elmaci Y; Perez-Guzman PN; Whittles LK; Kanapram DT; Gaythorpe KA; Hinsley W; Djaafara BA; Wang H; Fraser K; FitzJohn RG; Hogan AB; Doohan P; Ghani AC; Ferguson NM; Baguelin M; Cori A, Quantifying the impact of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study, http://dx.doi.org/10.1101/2022.08.08.22278528

Mesa DO; Hogan A; Watson O; Charles G; Hauck K; Ghani AC; Winskill P, Quantifying the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic, http://dx.doi.org/10.21203/rs.3.rs-343127/v1

Bents S; Viboud C; Grenfell B; Hogan A; Tempia S; von Gottberg A; Moyes J; Walaza S; Cohen C; Baker R, The impact of COVID-19 non-pharmaceutical interventions on future respiratory syncytial virus transmission in South Africa, http://dx.doi.org/10.1101/2022.03.12.22271872

Hogan AB; Wu SL; Doohan P; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC, The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant, http://dx.doi.org/10.1101/2022.01.17.22269222

Hogan AB; Winskill P; Watson OJ; Walker PGT; Whittaker C; Baguelin M; Brazeau NF; Charles GD; Gaythorpe KAM; Hamlet A; Knock E; Laydon DJ; Lees JA; Løchen A; Verity R; Whittles LK; Muhib F; Hauck K; Ferguson NM; Ghani AC, Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis, http://dx.doi.org/10.1101/2021.03.19.21253960

Back to profile page